Ketamine Therapy in Milwaukee, WI

Key Takeaways

• Ketamine therapy is an evidence based option for treatment resistant depression and certain trauma related conditions when traditional treatments have not worked.
• Esketamine is FDA approved for treatment resistant depression, while IV ketamine is used off label under medical supervision.
• Ketamine may reduce depressive symptoms more rapidly than traditional antidepressants, sometimes within hours to days.
• Ketamine assisted psychotherapy integrates medical treatment with structured therapy to support longer term change.
• Careful screening and medical monitoring are essential to ensure safety and appropriateness.

If you are exploring ketamine therapy because other treatments have not helped, you are not alone. Many people reach this point after months or years of trying medications or therapy without meaningful relief. There are options. It is important to approach them thoughtfully and with qualified providers.

What Is Ketamine Therapy?

Ketamine therapy is a medically supervised treatment used primarily for treatment resistant depression and certain trauma related conditions.

Ketamine has been used safely as an anesthetic since the 1960s. In recent years, research published in peer reviewed journals has demonstrated its rapid antidepressant effects, particularly for individuals diagnosed with Major Depressive Disorder under DSM 5 criteria who have not responded to at least two adequate medication trials.

A related medication, esketamine, is FDA approved for treatment resistant depression and is administered intranasally in certified medical settings. IV ketamine is commonly used off label in psychiatric contexts under physician supervision.

In clinical settings, ketamine is sometimes combined with psychotherapy, often referred to as Ketamine Assisted Psychotherapy. This model integrates the neurobiological effects of ketamine with structured therapeutic processing.

How Does Ketamine Work in the Brain?

Ketamine works by modulating glutamate activity and promoting neuroplasticity.

Unlike traditional antidepressants that primarily target serotonin or norepinephrine systems, ketamine blocks NMDA receptors, which leads to increased glutamate release. This cascade appears to stimulate synaptic growth and enhance neural connectivity. Research suggests that this mechanism may help disrupt entrenched depressive thought patterns and support new learning.

According to the American Psychological Association and National Institute of Mental Health, this rapid neurobiological shift may explain why some patients experience symptom relief within hours to days rather than weeks.

It is important to note that ketamine does not cure depression. It appears to create a window of increased neuroplasticity that can enhance the effectiveness of psychotherapy and behavioral change.

Who Is a Candidate for Ketamine Therapy?

Ketamine therapy is generally considered for individuals with treatment resistant or severe mood disorders.

In our Milwaukee practice, we typically see ketamine considered for:

• Major Depressive Disorder that has not responded to multiple antidepressants
• Persistent suicidal ideation requiring rapid intervention
• Post Traumatic Stress Disorder
• Obsessive Compulsive Disorder in select cases
• Certain chronic pain conditions with comorbid depression

These diagnoses align with DSM 5 categories such as Depressive Disorders, Trauma and Stressor Related Disorders, and Obsessive Compulsive and Related Disorders.

A comprehensive psychiatric and medical evaluation is essential. Individuals with active psychosis, uncontrolled hypertension, certain cardiac conditions, or a history of substance use disorders may not be appropriate candidates.

What Types of Ketamine Treatment Exist?

There are several medical delivery methods, each with different regulatory status.

• Intranasal esketamine is FDA approved for treatment resistant depression and is administered in certified clinics with post treatment monitoring.
• Intravenous ketamine is used off label and allows for precise dose control under physician supervision.
• Intramuscular ketamine is used in some medical settings with structured monitoring.
• Ketamine Assisted Psychotherapy integrates ketamine administration with therapeutic processing sessions before and after dosing.

The choice of method should be determined by a licensed prescriber in collaboration with the patient, based on clinical history and risk profile.

What Is the Typical Course of Treatment?

A typical acute course involves 6 to 8 sessions over 2 to 4 weeks, followed by maintenance treatments as clinically indicated.

Many protocols begin with multiple sessions in close succession. Ongoing booster sessions may be recommended depending on symptom recurrence.

Research suggests that while some individuals experience rapid symptom reduction, sustained improvement often requires integration with ongoing psychotherapy such as CBT, trauma therapy, or other structured modalities.

In our clinical experience, ketamine works best as part of a broader treatment plan rather than as a standalone intervention.

Is Ketamine Therapy Safe?

Ketamine therapy is generally well tolerated when administered in controlled medical settings, but it carries risks.

Common short term effects include dissociation, nausea, elevated blood pressure, and temporary perceptual changes. These typically resolve within hours.

Rare but serious risks include exacerbation of psychosis or emergence of suicidal thinking. This is why structured screening and monitoring are non negotiable.

Patients are required to arrange transportation after treatment and should not drive or operate machinery the same day. Repeated dosing requires careful monitoring to reduce risk of misuse or dependency.

Ongoing research continues to evaluate long term safety and optimal protocols.

How Does Ketamine Compare to Antidepressants or ECT?

Ketamine may act more rapidly than traditional antidepressants, but it is not a first line treatment.

Standard antidepressants remain first line for Major Depressive Disorder according to clinical guidelines. Electroconvulsive Therapy remains highly effective for severe or psychotic depression.

Ketamine is typically considered when individuals have not responded to other evidence based treatments. Research suggests significant symptom reduction in many treatment resistant cases, but long term comparative data are still developing.

Treatment decisions should always be collaborative and individualized.

Do We Offer Ketamine Therapy at Shoreside Therapies?

Shoreside Therapies provides psychotherapy and may collaborate with medical providers who offer ketamine services.

As a psychotherapy practice serving Milwaukee, Whitefish Bay, Glendale, and teletherapy clients across Wisconsin, our role is often to:

• Conduct diagnostic assessment
• Provide ongoing therapy
• Coordinate care with prescribing physicians
• Offer integration therapy following medical treatments

If you are exploring ketamine, we can help you evaluate whether it aligns with your treatment goals and coordinate appropriately.

Frequently Asked Questions

Is ketamine therapy approved by the FDA for depression?

Esketamine is FDA approved for treatment resistant depression, while IV ketamine is used off label. Off label use is legal and common in medicine when supported by research and clinical judgment. Treatment must occur in certified or medically supervised settings. A licensed prescriber determines appropriateness.

How quickly does ketamine work for depression?

Some individuals experience symptom relief within hours to days. This is significantly faster than traditional antidepressants, which may take several weeks. However, response varies, and not everyone improves. Ongoing therapy is often necessary for sustained benefit.

Can ketamine therapy help with PTSD?

Emerging research suggests ketamine may reduce symptoms associated with PTSD, particularly when combined with trauma focused psychotherapy. PTSD is categorized under Trauma and Stressor Related Disorders in the DSM 5. It is not considered a standalone cure. Careful screening is required.

Is ketamine therapy covered by insurance?

Insurance coverage varies. Esketamine is more commonly covered because it has FDA approval for treatment resistant depression. IV ketamine is often self pay. It is important to verify benefits directly with your insurer.

What are the risks of ketamine therapy?

Short term effects can include dissociation, elevated blood pressure, and nausea. Rare risks include worsening psychiatric symptoms in vulnerable individuals. Proper screening and medical monitoring significantly reduce risk. It is not appropriate for everyone.